Cathelicidin hCAP18/LL-37 promotes cell proliferation and suppresses antitumor activity of 1,25(OH)(2)D(3) in hepatocellular carcinoma

Cathelicidin hCAP18/LL-37 can resist infection from various pathogens and is an essential component of the human immune system. Accumulating evidence has indicated that hCAP18/LL-37 plays a tissue-specific role in human cancer. However, its function in hepatocellular carcinoma (HCC) is poorly unders...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Huidan, Zhen, Junai, Zhang, Rong, Wanyan, Yangke, Liu, Kehang, Yuan, Xueli, Tao, Liping, Chen, Yuqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763942/
https://www.ncbi.nlm.nih.gov/pubmed/35039485
http://dx.doi.org/10.1038/s41420-022-00816-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763942/
https://www.ncbi.nlm.nih.gov/pubmed/35039485
http://dx.doi.org/10.1038/s41420-022-00816-w

Ejemplares similares